Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2010 1
2011 1
2012 1
2013 1
2014 2
2017 1
2022 1
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study.
Miri S, Rosendaal FR, Kavakli K, Eshghi P, Moghaddam SM, Scardo S, Habibpanah B, Elalfy M, Halimeh S, Nicolò G, Gökçebay D, Özbek N, Celkan T, Mohammadi A, Karimi M, Shahsavani A, Yılmaz B, Albayrak C, Gunes B, Kaya Z, Ay Y, Akbayram S, Sarper N, Mannucci PM, Peyvandi F; PUP-SWITCH Study Group. Miri S, et al. Res Pract Thromb Haemost. 2024 Oct 18;8(8):102595. doi: 10.1016/j.rpth.2024.102595. eCollection 2024 Nov. Res Pract Thromb Haemost. 2024. PMID: 39649130 Free PMC article.
The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.
Conget I, Battelino T, Giménez M, Gough H, Castañeda J, Bolinder J; SWITCH Study Group. Conget I, et al. Diabetes Technol Ther. 2011 Jan;13(1):49-54. doi: 10.1089/dia.2010.0107. Diabetes Technol Ther. 2011. PMID: 21175271 Free article. Clinical Trial.
Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study.
Hommel E, Olsen B, Battelino T, Conget I, Schütz-Fuhrmann I, Hoogma R, Schierloh U, Sulli N, Gough H, Castañeda J, de Portu S, Bolinder J; SWITCH Study Group. Hommel E, et al. Acta Diabetol. 2014 Oct;51(5):845-51. doi: 10.1007/s00592-014-0598-7. Epub 2014 Jul 19. Acta Diabetol. 2014. PMID: 25037251 Free PMC article. Clinical Trial.
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
Jørgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mørk C, Jahnsen J, Kvien TK; NOR-SWITCH study group. Jørgensen KK, et al. Lancet. 2017 Jun 10;389(10086):2304-2316. doi: 10.1016/S0140-6736(17)30068-5. Epub 2017 May 11. Lancet. 2017. PMID: 28502609 Clinical Trial.